| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case Series Study of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Early Evaluation of the Response to Systemic Therapy in Metastatic Renal Cancer
|
Seront, Emmanuel
|
|
|
7 |
5 |
p. 1147-1149
|
artikel
|
| 2 |
A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal Disparities
|
Cussenot, Olivier
|
|
|
7 |
5 |
p. 978-981
|
artikel
|
| 3 |
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study
|
Flippot, Ronan
|
|
|
7 |
5 |
p. 1132-1140
|
artikel
|
| 4 |
A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)
|
Tombal, Bertrand F.
|
|
|
7 |
5 |
p. 1051-1060
|
artikel
|
| 5 |
Association of Age with Non–muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
|
Lobo, Niyati
|
|
|
7 |
5 |
p. 1069-1079
|
artikel
|
| 6 |
Contents
|
|
|
|
7 |
5 |
p. iii-vii
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
7 |
5 |
p. i-ii
|
artikel
|
| 8 |
Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis
|
Cerrato, Clara
|
|
|
7 |
5 |
p. 1005-1014
|
artikel
|
| 9 |
Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing and Existing Data Suggest How to Mitigate Toxicity
|
Cordes, Lisa M.
|
|
|
7 |
5 |
p. 971-972
|
artikel
|
| 10 |
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial
|
Ross, Ashley E.
|
|
|
7 |
5 |
p. 1024-1033
|
artikel
|
| 11 |
Fluorine-18–labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)
|
Wong, Lih-Ming
|
|
|
7 |
5 |
p. 1015-1023
|
artikel
|
| 12 |
How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial
|
Padden-Modi, Minal
|
|
|
7 |
5 |
p. 990-992
|
artikel
|
| 13 |
Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy
|
Ben-David, Reuben
|
|
|
7 |
5 |
p. 1105-1112
|
artikel
|
| 14 |
Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study
|
Xie, Jun
|
|
|
7 |
5 |
p. 1088-1096
|
artikel
|
| 15 |
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy
|
Fletcher, Sean A.
|
|
|
7 |
5 |
p. 1061-1068
|
artikel
|
| 16 |
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study
|
Massari, Francesco
|
|
|
7 |
5 |
p. 1123-1131
|
artikel
|
| 17 |
Performance of a Region of Interest–based Algorithm in Diagnosing International Society of Urological Pathology Grade Group ≥2 Prostate Cancer on the MRI-FIRST Database—CAD-FIRST Study
|
Couchoux, Thibaut
|
|
|
7 |
5 |
p. 1113-1122
|
artikel
|
| 18 |
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712
|
Rana, Zaker
|
|
|
7 |
5 |
p. 986-989
|
artikel
|
| 19 |
Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer
|
Chavarriaga, Julian
|
|
|
7 |
5 |
p. 1034-1041
|
artikel
|
| 20 |
Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial
|
Wegener, Eric
|
|
|
7 |
5 |
p. 1042-1050
|
artikel
|
| 21 |
Radiotherapy Combined with a Radiosensitizer for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Carcinoma In Situ Bladder Cancer: An Open-label, Single-arm, Multicenter, Phase 2 European Organisation for Research and Treatment of Cancer Trial
|
Achard, Vérane
|
|
|
7 |
5 |
p. 982-985
|
artikel
|
| 22 |
Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.11.008
|
Guidotti, Alessio
|
|
|
7 |
5 |
p. 1156-1157
|
artikel
|
| 23 |
Re: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, et al. Overall Survival with [177Lu]Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-resistant Prostate Cancer (TheraP): Secondary Outcomes of a Randomised, Open-label, Phase 2 Trial. Lancet Oncol 2024;25:99–107
|
Xu, Jing
|
|
|
7 |
5 |
p. 1150-1151
|
artikel
|
| 24 |
Removing Barriers to the Use of Systemic Agents for Patients with von Hippel-Lindau Disease
|
Larcher, Alessandro
|
|
|
7 |
5 |
p. 1141-1143
|
artikel
|
| 25 |
Re: Ost P, Siva S, Brabrand S, et al. PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
|
Montorsi, Francesco
|
|
|
7 |
5 |
p. 1154
|
artikel
|
| 26 |
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti’s Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V—Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
|
Zilli, Thomas
|
|
|
7 |
5 |
p. 1152-1153
|
artikel
|
| 27 |
Reply to Marco Bandini, Andrea Salonia, and Francesco Montorsi’s Letter to the Editor re: Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries, et al. Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005
|
Elst, Laura
|
|
|
7 |
5 |
p. 1155
|
artikel
|
| 28 |
Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials
|
Jones, Craig
|
|
|
7 |
5 |
p. 993-1004
|
artikel
|
| 29 |
Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology
|
Salgia, Nicholas J.
|
|
|
7 |
5 |
p. 973-977
|
artikel
|
| 30 |
Surgery Remains an Integral Part of Multimodal Treatment for High-risk Prostate Cancer
|
Heidenreich, Axel
|
|
|
7 |
5 |
p. 969-970
|
artikel
|
| 31 |
The Role of Cytomegalovirus in Prostate Cancer Incidence and Mortality
|
Classon, Johanna
|
|
|
7 |
5 |
p. 1144-1146
|
artikel
|
| 32 |
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide
|
Parikh, Mamta
|
|
|
7 |
5 |
p. 1097-1104
|
artikel
|
| 33 |
Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1)
|
Ploussard, Guillaume
|
|
|
7 |
5 |
p. 1080-1087
|
artikel
|
Tijdschrift beschrijving